XML 75 R42.htm IDEA: XBRL DOCUMENT v3.20.1
Stock Compensation Plan (Tables)
12 Months Ended
Dec. 31, 2019
Schedule of Fair Value of Options Assumed

The fair value of the options granted were determined using the following weighted-average assumptions as of the grant date:

 

    Years ended December 31,  
    2019     2018     2017  
Risk-free interest rate     1.77 %     n/a       2.07 %
Expected term     7 year       n/a       7 year  
Expected stock price volatility     26.06 %     n/a       33.30 %
Dividend yield     3.41 %     n/a       2.74 %

Schedule of Share-based Compensation, Stock Options, Activity

A summary of option activity during 2019 is presented below:

 

(Dollars in thousands, except per share amounts)         Weighted     Weighted        
          average     average        
          exercise     remaining     Aggregate  
          price     contractual     intrinsic  
    Shares     per share     term     value  
Outstanding at January 1, 2019     68,706     $ 17.97       5.1 years     $ 462  
Granted     64,405     $ 23.44                  
Effect of 5% stock dividend     6,504                          
Forfeited/expired     -     $ -                  
Exercised     (3,275 )   $ 10.99                  
Outstanding at December 31, 2019     136,340     $ 19.87       6.9 years     $ 714  
Exercisable at December 31, 2019     49,558     $ 14.43       3.0 years     $ 529  
Fully vested options at December 31, 2019     49,558     $ 14.43       3.0 years     $ 529  

Schedule of Stock Option Exercised Additional Information

Additional information about stock options exercised is presented below:

 

(Dollars in thousands)   Years ended December 31,  
    2019     2018     2017  
Intrinsic value of options exercised (on exercise date)   $ 42     $ 1,523     $ 279  
Cash received from options exercised     36       534       228  
Excess tax benefit realized from options exercised   $ -     $ 136     $ 103  

Schedule of Share-based Compensation Arrangements by Share-based Payment Award

(Dollars in thousands)      
Year   Amount  
2020   $ 130  
2021     104  
2022     68  
2023     40  
Total   $ 342  

Restricted Stock [Member]  
Schedule of Share-based Compensation Arrangements by Share-based Payment Award

(Dollars in thousands)      
Year   Amount  
2020   $ 132  
2021     58  
2022     34  
Total   $ 224  

Schedule of Nonvested Share Activity

A summary of nonvested restricted common stock activity during 2019 is presented below:

 

    Shares     Weighted average grant date price per share  
Nonvested restricted common stock at January 1, 2019     16,800     $ 25.87  
Granted     3,416     $ 23.44  
Vested     (6,346 )   $ 26.08  
Effect of 5% stock dividend     682          
Nonvested restricted common stock at December 31, 2019     14,552     $ 23.98